The COP regimen is not a feasible treatment for advanced, refractory chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 23, Issue 1-2, 1996, Pages 137-141

  Itälä, Maija ^a   Remes, Kari ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Chemotherapy; Refractory chronic lymphocytic leukemia

Indexed keywords

ALKYLATING AGENT; CLADRIBINE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; FLUDARABINE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEPSIS;

EID: 0029803796     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054812     Document Type: Article

References (28)

1. Rozman, C, and Montserrat, E. (1995) Chronic lymphocytic leukemia. N. Engl. J. Med., 333, 1052-1057.
2. Catovsky, D., Fooks, J. and Richards, S. (1988) The UK Medical Research Council CLL trials 1 and 2. Nouv. Rev. Fr. Hematol., 30, 423-427.
3. Catovsky, D., Richards, S., Fooks, J. and Hamblin, T. J. (1991) CLL trials in the United Kingdom. The Medical research Council CLL trials 1, 2 and 3. Leuk. Lymphoma, 5 (Suppl.), 105-112.
4. French Cooperative Group on Chronic Lymphocytic Leukemia (1990) A randomized trial of chlorambucil versus COP in stage B chronic lymphocytic leukemia. Blood, 75, 1422-1425.
5. Montserrat, E., Alcala, A., Parody, R., Domingo, A., Garcia-Conde, J., Bueno, J., Ferran, C., Sanz, M. A., Giralt, M., Rubio, D., Anton, I., Estape, J. and Rozman, C. (1985) Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisone. Cancer, 56, 2369-2375.
6. Raphael B., Andersen, J. W., Silber, R., Oken, M., Moore, D., Bennett, J., Bonner, H., Hahn, R., Knospe, W. H., Mazza, J. and Glick, J. (1991) Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: Long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial. J. Clin. Oncol., 9, 770-776.
7. Liepman, M. and Votaw, M. L. (1978) The treatment of chronic lymphocytic leukemia with COP chemotherapy. Cancer, 41, 1664-1669.
8. French Cooperative Group on Chronic Lymphocytic Leukemia (1994) Is the CHOP regimen a good treatment for advanced CLL? Results from two randomized clinical trials. Leuk. Lymphoma, 13, 449-456.
9. Hansen, M. M., Andersen, E., Christensen, B. E., Cristiansen, I., Geisler, G., Kristensen, D., Jensen, K. B. and Junker, P. (1988) CHOP versus prednisolone + chlorambucil in chronic lymphocytic leukemia: Preliminary results of a randomized multicenter study. Nouv. Rev. Fr. Hematol, 30, 433-436.
10. Kimby, E. and Mellstedt, H. (1991) Chlorambucil/prednisone versus CHOP in symptomatic chronic lymphocytic leukemias of B-cell type A randomized trial. Leuk. Lymphoma, 5 (Suppl.), 93-96.
11. Binet, J. L., Auquier, A., Dighiero, G., Chastang, C., Piguet, J., Goasguen, J., Vaugier, G., Potron, G., Colona, P., Oberling, F., Thomas, M., Tchernia, G , Jacquillat, C , Boivin, P., Lesty, C., Duault, M. T., Monconduit, M., Belabbes, S. and Gremy, F. (1981) A new prognostic classification of chronic lymphocytic leukemia from a multivariate survival analysis. Cancer, 48, 198-206.
12. International Workshop on Chronic Lymphocytic Leukemia (1989) Chronic lymphocytic leukemia: Recommendations for diagnosis, staging, and response criteria. Ann. Intern. Med., 110, 236-238.
13. Oken, M. M. and Kaplan, E. K. (1979) Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in the treatment of refractory chronic lymphocytic leukemia. Cancer Treatm. Rep., 63, 441-447.
14. Juliusson, G. and Liliemark, J (1994) Retreatment of chronic lymphocytic leukemia with 2-Chlorodeoxyadenosine (CdA) at relapse following CdA-induced remission: No acquired resistance. Leuk. Lymphoma, 13, 75-80.
15. O'Brien, S., Kantarjian, H., Beran, M., Robertson, L. E., Koller, C., Lerner, S. and Keating, M. J. (1995) Interferon maintenance therapy for patients with chronic lymphocytic leukemia in remission after fludarabine therapy Blood, 86, 1296-1300.
16. Molica, S. (1994) High-dose dexamethasone in refractory B-cell chronic lymphocytic leukemia. Am. J. Hematol., 47, 324.
17. Friedenberg, W. R., Anderson, J., Wolf, B. C., Cassileth, P. A. and Oken, M. (1993) Modified vincristine, doxorubicin, and dexamethasone regimen in the treatment of resistant or relapsed chronic lymphocytic leukemia. Cancer, 71, 2983-2989.
18. Keating, M. J., Scouros, M., Murphy, S., Kantarjian, H., Hester, J., McCredie, K. B., Hersh, E. M. and Freireich, E. J. (1988) Multiple agent chemotherapy (POACH) in previously treated and untreated patients with chronic lymphocytic leukemia. Leukemia, 2, 157-164.
19. Grever, M. R., Kopecky, K. J., Coltman, C. A., Files, J. C., Greenberg, B. R., Hutton, J. J., Talley, R., Von Hoff, D. D. and Balcerzak, S. P. (1988) Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia. Nouv. Rev. Fr. Hematol., 30, 457-459.
20. Hiddemann, W., Rottmann, R., Wörmann, B , Thiel, A., Essink, M., Ottensmeier, C., Freund, M., Büchner, T. and van de Loo, J. (1991) Treatment of advanced chronic lymphocytic leukemia by fludarabine. Ann. Hematol., 63, 1-4.
21. th Congress of the International Society of Haematology, Abstract Book, p. 14.
22. Bergmann, L., Fenchel, K., Jahn, B., Mitrou, P. S. and Hoelzer, D. (1993) Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia. Ann. Oncol., 4, 371-375.
23. Keating, M. J., O'Brien, S., Kantarjian, H., Plunkett, W., Estey, E., Koller, C., Beran, M. and Freireich, E. J. (1993) Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent. Blood, 81, 2878-2884.
24. Zinzani, P. L., Lauria, F., Rondelli, D., Benfenati, D., Raspadori, D., Bocchia, M., Gozzetti, A., Cavo, M., Cirio, T. M., Zaja, F., Russo, D., Fanin, R., Galieni, P., Algeri, R., Fiacchini, M. and Tura, S. (1993) Fludarabine in patients with advanced and/or resistant B-chronic lymphocytic leukemia. Eur. J. Haematol., 51, 93-97.
25. Gillis, S., Dann, E. J., Cass, Y., Rochlemer, R. and Polliack, A. (1994) Activity in refractory chronic lymphocytic leukemia and low grade non-Hodgkin's lymphoma - the Jerusalem experience Leuk. Lymphoma, 15, 173-175.
26. Saven, A., Carrera, C. J., Carson, D. A., Beutler, E. and Piro, L. D. (1994) 2-Chlorodeoxyadenosine treatment of refractory chronic lymphocytic leukemia. Leuk. Lymphoma, Suppl., pp. 133-138.
27. O'Brien, S., Kantarjian, H., Estey, E., Koller, C., Robertson, B , Beran, M , Andreeff, M., Pierce, S. and Keating, M. (1994) Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy. N. Engl. J Med., 330, 319-322.
28. Tallman, M. S , Hakimian, D., Zanzig, C., Hogan, D. K., Rademaker, A., Rose, E. and Vanakojis, D. (1995) Cladribine in the treatment of relapsed or refractory chronic lymphocytic leukemia. J. Clin. Oncol., 13, 983-988.